One year in review 2016: spondyloarthritis

Alice Parma; Laura Cometi; Maria Comasia Leone; Gemma Lepri; Rosaria Talarico; Serena Guiducci

One year in review 2016: spondyloarthritis

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):3-17. Epub 2017 Jan 26.

Authors

Alice Parma¹, Laura Cometi², Maria Comasia Leone³, Gemma Lepri², Rosaria Talarico⁴, Serena Guiducci²

Affiliations

¹ Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
² Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Italy.
³ Rheumatology Unit, University of Perugia, Italy.
⁴ Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. sara.talarico76@gmail.com.

PMID: 28150582

Abstract

Spondyloarthritis represents a heterogeneous group of articular inflammatory diseases that share common genetic, clinical and radiological features. Recently, novel insights into the epidemiology, pathogenesis and treatment of these diseases have been provided. Herewith, we present an overview ofthe most significant literature contributions published over the past year.

Publication types

Review

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Antirheumatic Agents / therapeutic use
Biological Products / therapeutic use
Cytokines / metabolism
Humans
Incidence
Prevalence
Spondylarthritis / drug therapy*
Spondylarthritis / epidemiology*
Spondylarthritis / etiology

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Biological Products
Cytokines